Back to Search
Start Over
Inhibitory kinetics and mechanism of pentacyclic triterpenoid from endophytic Colletotrichum gigasporum against pancreatic lipase.
- Source :
-
International journal of biological macromolecules [Int J Biol Macromol] 2021 Apr 01; Vol. 175, pp. 270-280. Date of Electronic Publication: 2021 Feb 06. - Publication Year :
- 2021
-
Abstract
- The burden of obesity is increasing all over the world. Except for Orlistat, no effective anti-obesity drug is currently available. Therefore, a search for the new anti-obesity compound is need of time. This study demonstrates macromolecular interaction and inhibitory effect of pentacyclic triterpenoids (PTT) on pancreatic lipase (PL). In the present study PTTs from endophytic Colletotrichum gigasporum were found to show significant inhibitory activity against PL with IC <subscript>50</subscript> of 16.62 ± 1.43 μg/mL. The PTT isolated through bioassay-guided isolation showed a dose-dependent (R <superscript>2</superscript>  = 0.915) inhibition against porcine PL and the results were comparable with the standard (Orlistat). Based on inhibition kinetic data, the gradual increase in K <subscript>m (app)</subscript> with increasing PTT concentration indicated that the mode of interaction of PTT with PL was a competitive type, and it directly competed with the substrate (pNPB) for the active site of PL. In vivo studies in Wistar rats at the oral dose (100 mg/kg body weight) of PTT significantly decreased (p < 0.05) incremental plasma triglyceride levels as compared to group B and TG absorption was down-regulated up to 49.18% vis a vis group D animals. The isolated PTT was identified as lupeol based on chromatographic and spectral data. The endophytic isolate was identified as Colletotrichum gigasporum based on morphology and ITS gene sequencing. The present study indicated that PTT had the potential to be used as a natural PL inhibitor in the treatment of obesity and the isolated endophyte can be a valuable bioresource for it.<br />Competing Interests: Declaration of competing interest The authors declare no conflict of interest.<br /> (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Anti-Obesity Agents pharmacology
Catalytic Domain
Endophytes
Enzyme Inhibitors pharmacology
Humans
Inhibitory Concentration 50
Kinetics
Lipase chemistry
Lipase metabolism
Male
Molecular Structure
Obesity drug therapy
Orlistat pharmacology
Pancreas metabolism
Pentacyclic Triterpenes chemistry
Pentacyclic Triterpenes metabolism
Rats
Rats, Wistar
Structure-Activity Relationship
Swine
Triterpenes pharmacology
Colletotrichum metabolism
Lipase antagonists & inhibitors
Pentacyclic Triterpenes pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0003
- Volume :
- 175
- Database :
- MEDLINE
- Journal :
- International journal of biological macromolecules
- Publication Type :
- Academic Journal
- Accession number :
- 33561462
- Full Text :
- https://doi.org/10.1016/j.ijbiomac.2021.02.036